J. Safra Sarasin Holding’s AbbVie ABBV Stock Holding History

J. Safra Sarasin Holding’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$73.3M	Buy	336,967 +25,665	+8%	+$5.69M	1.25%	18
2025 Q4	$71.1M	Sell	311,302 -36,172	-10%	-$8.24M	1.16%	20
2025 Q3	$80.4M	Buy	347,474 +62,723	+22%	+$12.8M	1.3%	18
2025 Q2	$52.8M	Buy	284,751 +149,378	+110%	+$27.8M	0.91%	37
2025 Q1	$28.3M	Buy	135,373 +95,460	+239%	+$18.6M	0.51%	57
2024 Q4	$7.08M	Buy	39,913 +19,863	+99%	+$3.65M	0.12%	123
2024 Q3	$3.94M	Sell	20,050 -40	-0.2%	-$7.46K	0.07%	150
2024 Q2	$3.45M	Buy	+20,090	New	+$3.33M	0.06%	164

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

J. Safra Sarasin Holding's ABBV Position: Q1 2026 in Review

J. Safra Sarasin Holding increased its AbbVie (ABBV) stake by 8.2% in Q1 2026, buying an estimated $5.69M and bringing the position to 336,967 shares worth $73.3M. The position accounts for 1.25% of the portfolio, ranked #18.

J. Safra Sarasin Holding first reported a position in ABBV in Q2 2024 and has held it in 8 quarters since. The position peaked at $80.4M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

J. Safra Sarasin Holding held 336,967 shares of AbbVie worth $73.3M as of Q1 2026.
J. Safra Sarasin Holding bought 25,665 AbbVie shares in Q1 2026, an estimated $5.69M.
AbbVie made up 1.25% of J. Safra Sarasin Holding's portfolio in Q1 2026, its #18 holding.
J. Safra Sarasin Holding first reported a position in AbbVie in Q2 2024 and has held it in 8 quarters since.
J. Safra Sarasin Holding's AbbVie position peaked at $80.4M in Q3 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q1 2026, filed 4 May 2026.